Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studiesBrian J Lavey, Joseph A Kozlowski, R William Hipkin, et al.
The Journal of Biological Chemistry|May 17, 2000
Signaling by covalent heterodimers of interferon-gamma. Evidence for one-sided signaling in the active tetrameric receptor complexC D Krause, C A Lunn, L S Izotova, et al.
British Journal of Pharmacology|October 2, 2007
Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonistsC A Lunn, E-P Reich, J S Fine, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2008
Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitorsZhuyan Guo, Peter Orth, Shing-Chun Wong, et al.
Molecular Biology Reports|July 19, 2008
Molecular characterization of Pegarn: a Drosophila homolog of UNC-51 kinaseA Ahantarig, L V Chadwell, I B Terrazas, et al.
Immunopharmacology and Immunotoxicology|December 14, 2007
Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone lossCharles A Lunn, Jay Fine, Alberto Rojas-Triana, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonistWaldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
Nature Structural Biology|March 13, 1999
Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservationT O Fischmann, A Hruza, X D Niu, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Expansion of SAR studies on triaryl bis sulfone cannabinoid CB2 receptor ligandsLing Tong, B B Shankar, Lei Chen, et al.
Pageof 7